BioSim^TM - ELISA Kits for BioSimilar Antibodies

Human IgG based monoclonal antibodies (mAbs) are the fastest-growing category of therapeutics for cancer therapy. Several monoclonal antibodies have received FDA approval for the treatment of a variety of solid tumors and hematological malignancies. BioVision is pleased to offer one of the largest selections of ELISA Kits for detecting biosimilar antibodies and anti-drug antibodies in the research market. These ELISA Kits can be used to study dose-dependent pharmacokinetics, identify biomarkers for (non-)response, and risk factors for adverse drug reactions.

Key Features:

Rapid and Simple: No expensive equipment or special handling/disposal required
Accurate: Reproducible results with low intra & inter assay variability
Compatible samples: Human serum and plasma
Highly Sensitive and Specific

BEST Seller!!!!

BioSim™ Pembrolizumab (Keytruda®)(Human) ELISA Kit

Pembrolizumab (Keytruda) is a humanized monoclonal antibody that is approved by the U.S. Food and Drug Administration for the treatment of patients with unresectable or metastatic melanoma. Pembrolizumab binds to the human cell surface receptor PD-1 (Programmed Cell Death Protein 1) and blocks its interaction with PD-L1, resulting in the activation of T-cell-mediated immune responses against tumor cells.

Figure: Typical Standard Curve for BioSim™ Pembrolizumab (Keytruda®)(Human) ELISA Kit (Cat.No. E4383 )

Highlighted ELISA Kits for BioSimilar Antibodies and Anti-drug Antibodies:

Target	Tradename	Cat # for BioSimilar Antibodies	Cat # for Anti-drug Antibodies	Size
Adalimumab	Humira®	E4372	E4388	100 assays
Bevacizumab	Avastin®	E4373	E4389	100 assays
Cetuximab	Erbitux®	E4379	E4391	100 assays
Denosumab	Prolia®	E4380	E4394	100 assays
Etanercept	Enbrel®	E4374	E4392	100 assays
Golimumab	Simponi®	E4377	E4393	100 assays
Infliximab	Remicade®	E4375	E4387	100 assays
Ipilimumab	Yervoy®	E4384	E4398	100 assays
Nivolumab	Opdivo®	E4382	E4396	100 assays
Omalizumab	Xolair®	E4381	E4395	100 assays
Pembrolizumab	Keytruda®	E4383	E4397	100 assays
Rituximab	Mabthera®	E4371	E4385	100 assays
Trastuzumab	Herceptin®	E4376	E4386	100 assays
Avelumab	Bavencio	E4556	E4557	100 assays
Filgrastim	Neupogen	-	E4399	100 assays

Please click here to see BioVision's BioSim^TM ELISA Kits for BioSimilar antibodies and check out our Biosimilar Antibodies and ELISA Kits mini brochure.

Richiedi un'offerta

DBA-ITALIA Srl
Via Umbria 10
20090 Segrate (Milano)

Tel. +39 02-26922300
Fax +39 02-26926058
Fax +39 02-26923535

If you no longer wish to receive these announcements click here